(Q40694954)

English

Simultaneous determination of etoposide and its catechol metabolite in the plasma of pediatric patients by liquid chromatography/tandem mass spectrometry

scientific article published on July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Simultaneous determination of etoposide and its catechol metabolite in the plasma of pediatric patients by liquid chromatography/tandem mass spectrometry (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

based on heuristic

inferred from title

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

author name string

Pang S

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Zheng N

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Felix CA

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Scavuzzo J

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Boston R

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Blair IA

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Journal of Mass Spectrometry

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

771-781

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

describes a project that uses

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Mechanism of action of antitumor drug etoposide: a review

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Role of the semi-quinone free radical of the anti-tumour agent etoposide (VP-16-213) in the inactivation of single- and double-stranded phi X174 DNA.

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Repair of oxidative damage to DNA: enzymology and biology

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

In vitro metabolism of etoposide (VP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteins

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Effects of the ortho-quinone and catechol of the antitumor drug VP-16-213 on the biological activity of single-stranded and double-stranded phi X174 DNA.

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide.

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Catalytic function of DNA topoisomerase II.

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Substrates of human hepatic cytochrome P450 3A4.

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Association of CYP3A4 genotype with treatment-related leukemia

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Pharmacokinetics of anticancer drugs in children

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Inactivation of phi X174 DNA by the ortho-quinone derivative or its reduction product of the antitumor agent VP 16-213

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Analysis of the anticancer drugs etoposide (VP 16-213) and teniposide (VM 26) by high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Assay for etoposide in human serum using solid-phase extraction and high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

High-performance liquid chromatographic analysis of the semisynthetic epipodophyllotoxins teniposide and etoposide using electrochemical detection

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

High-performance liquid chromatographic method for the determination of etoposide in plasma using electrochemical detection

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

High-performance liquid chromatographic determination of etoposide in plasma using electrochemical detection

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Simultaneous quantitation of etoposide and its catechol metabolite in human plasma using high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Determination of the cytotoxic catechol metabolite of etoposide (3'O-demethyletoposide) in human plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Etoposide protein binding in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Relation of systemic exposure to unbound etoposide and hematologic toxicity

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Balancing needs, efficiency, and functionality in the provision of modeling software: a perspective of the NIH WinSAAM Project

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Considerable plasma levels of a cytotoxic etoposide metabolite in patients undergoing high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FJMS.173

21 January 2018

Identifiers

10.1002/JMS.173

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

release_5r232ranczgqlgpjjzlnm2vxta

1 reference

https://api.fatcat.wiki/v0/release/5r232ranczgqlgpjjzlnm2vxta

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40694954&oldid=2145759838"